Abstract
Pain is one of the most disabling clinical symptoms in patients with multiple sclerosis (MS). Several studies have already assessed the prevalence of pain in MS patients, reporting variable results, probably due to methodological differences. The aim of this single-centre cross-sectional study was to define the prevalence and characteristics of chronic pain in a population of MS patients using validated tools, and to analyse these data in relation to demographic and clinical features, including disease duration and disability (EDSS and its single functional system scores). Of 397 enrolled patients, 23 were excluded due to a Beck’s Depression Inventory Score > 19. In the remaining 374 patients, the overall prevalence of chronic pain was 52.1%, most frequently affecting the lower limbs (36.9%). Neuropathic pain was the most frequent type of chronic pain (89 patients, overall prevalence of 23.7%) and was associated with a sensory functional system involvement. Pain intensity was significantly higher in patients with neuropathic pain as opposed to patients with non-neuropathic pain. Patients with chronic pain and, in particular, patients with neuropathic pain had significantly higher EDSS scores than those without pain. Only 24% of patients with chronic pain and 33% of patients with neuropathic pain were on a specific long-lasting treatment for pain. The present study supports the routine assessment of neuropathic pain in MS patients, especially in those with a sensory functional system involvement, in order to avoid underdiagnosing and undertreating a potentially disabling condition.
Similar content being viewed by others
References
Clifford DB, Trotter JL (1984) Pain in multiple sclerosis. Arch Neurol 41(7):1270–1272. https://doi.org/10.1212/WNL.39.7.1001
Kalia LV, O’Connor PW (2005) Severity of chronic pain and its relationship to quality of life in multiple sclerosis. Mult Scler 11(3):322–327. https://doi.org/10.1191/1352458505ms1168oa
Khan F, Pallant J (2007) Chronic pain in multiple sclerosis: prevalence, characteristics, and impact on quality of life in an Australian community cohort. J Pain 8(8):614–623. https://doi.org/10.1016/j.jpain.2007.03.005
Martinelli Boneschi F, Colombo B, Annovazzi P, Martinelli V, Bernasconi L, Solaro C, Comi G (2008) Lifetime and actual prevalence of pain and headache in multiple sclerosis. Mult Scler 14(4):514–521. https://doi.org/10.1177/1352458507085551
Moulin DE (1989) Pain in multiple sclerosis. Neurol Clin 7(2):321–331
Solaro C, Trabucco E, Messmer Uccelli M (2013) Pain and multiple sclerosis: pathophysiology and treatment. Curr Neurol Neurosci Rep 13(1):320. https://doi.org/10.1007/s11910-012-0320-5
Hirsh AT, Turner AP, Ehde DM, Haselkorn JK (2009) Prevalence and impact of pain in multiple sclerosis: physical and psychologic contributors. Arch Phys Med Rehabil 90(4):646–651. https://doi.org/10.1016/j.apmr.2008.10.019
Foley PL, Vesterinen HM, Laird BJ, Sena ES, Colvin LA, Chandran S, MacLeod MR, Fallon MT (2013) Prevalence and natural history of pain in adults with multiple sclerosis: systematic review and meta-analysis. Pain 154(5):632–642. https://doi.org/10.1016/j.pain.2012.12.002
O’Connor AB, Schwid SR, Herrmann DN, Markman JD, Dworkin RH (2008) Pain associated with multiple sclerosis: systematic review and proposed classification. Pain 137(1):96–111. https://doi.org/10.1016/j.pain.2007.08.024
Campbell JN, Meyer RA (2006) Mechanisms of neuropathic pain. Neuron 52(1):77–92. https://doi.org/10.1016/j.neuron.2006.09.021
Scholz J, Woolf CJ (2002) Can we conquer pain? Nat Neurosci 5(Supp):1062–1067. https://doi.org/10.1038/nn942
Treede RD, Jensen TS, Campbell JN, Cruccu G, Dostrovsky JO, Griffin JW, Hansson P, Hughes R, Nurmikko T, Serra J (2008) Neuropathic pain: redefinition and a grading system for clinical and research purposes. Neurology 70(18):1630–1635. https://doi.org/10.1212/01.wnl.0000282763.29778.59
Turk DC, Okifuji A (2001) Pain terms and taxonomies. In: Loeser D, Butler SH, Chapman JJ, Turk DC (eds) Bonica’s Manag. Pain, 3rd edn. Lippincott Williams & Wilkins, Philadelphia, pp 18–25
Main CJ, Spanswick CC (2000) Pain management: an interdisciplinary approach. Churchill Livingstone, London
Breivik H, Collett B, Ventafridda V, Cohen R, Gallacher D (2006) Survey of chronic pain in Europe: prevalence, impact on daily life, and treatment. Eur J Pain 10(4):287–333. https://doi.org/10.1016/j.ejpain.2005.06.009
Merskey H, Bogduk N (1994) Classification of chronic pain. IASP Pain Terminol 57(3):425–429. https://doi.org/10.1002/ana.20394
Truini A, Barbanti P, Pozzilli C, Cruccu G (2013) A mechanism-based classification of pain in multiple sclerosis. J Neurol 260(2):351–367. https://doi.org/10.1007/s00415-012-6579-2
Chopra K, Arora V (2014) An intricate relationship between pain and depression: clinical correlates, coactivation factors and therapeutic targets. Expert Opin Ther Targets 18(2):159–176. https://doi.org/10.1517/14728222.2014.855720
Hadjimichael O, Kerns RD, Rizzo MA, Cutter G, Vollmer T (2007) Persistent pain and uncomfortable sensations in persons with multiple sclerosis. Pain 127(1):35–41. https://doi.org/10.1016/j.pain.2006.07.015
Fishbain DA, Cutler R, Rosomoff HL, Rosomoff RS (1997) Chronic pain-associated depression: antecedent or consequence of chronic pain? A review. Clin J Pain 13(2):116–137. https://doi.org/10.1097/00002508-199706000-00006
Alschuler KN, Ehde DM, Jensen MP (2013) Co-occurring depression and pain in multiple sclerosis. Phys Med Rehabil Clin N Am 24(4):703–715. https://doi.org/10.1016/j.pmr.2013.06.001
Kurtzke JF (1983) Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 33(11):1444–1452. https://doi.org/10.1212/WNL.33.11.1444
Stenager E, Knudsen L, Jensen K (1995) Acute and chronic pain syndromes in multiple sclerosis. A 5-year follow-up study. Ital J Neurol Sci 16(8):629–632. https://doi.org/10.1007/BF02230913
Heitmann H, Biberacher V, Tiemann L, Buck D, Loleit V, Selter RC, Knier B, Tölle TR, Mühlau M, Berthele A, Hemmer B, Ploner M (2015) Prevalence of neuropathic pain in early multiple sclerosis. Mult Scler J 22(9):8–11. https://doi.org/10.1177/1352458515613643
Polman CH, Reingold SC, Banwell B, Clanet M, Cohen JA, Filippi M, Fujihara K, Havrdova E, Hutchinson M, Kappos L, Lublin FD, Montalban X, O'Connor P, Sandberg-Wollheim M, Thompson AJ, Waubant E, Weinshenker B, Wolinsky JS (2011) Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol 69(2):292–302. https://doi.org/10.1002/ana.22366
Ohayon MM, Stingl JC (2012) Prevalence and comorbidity of chronic pain in the German general population. J Psychiatr Res 46(4):444–450. https://doi.org/10.1016/j.jpsychires.2012.01.001
Blyth FM, March LM, Brnabic AJM, Jorm LR, Williamson M, Cousins MJ (2001) Chronic pain in Australia: a prevalence study. Pain 89(2):127–134. https://doi.org/10.1016/S0304-3959(00)00355-9
Caraceni A, Mendoza TR, Mencaglia E, Baratella C, Edwards K, Forjaz MJ, Martini C, Serlin RC, de Conno F, Cleeland CS (1996) A validation study of an Italian version of the Brief Pain Inventory (Breve Questionario per la Valutazione del Dolore). Pain 65(1):87–92. https://doi.org/10.1016/0304-3959(95)00156-5
De Benedittis G, Massei R, Nobili R, Pieri A (1988) The Italian pain questionnaire. Pain 33(1):53–62. https://doi.org/10.1016/0304-3959(88)90203-5
Bouhassira D, Attal N, Fermanian J, Alchaar H, Gautron M, Masquelier E, Rostaing S, Lanteri-Minet M, Collin E, Grisart J, Boureau F (2004) Development and validation of the Neuropathic Pain Symptom Inventory. Pain 108(3):248–257. https://doi.org/10.1016/j.pain.2003.12.024
Spallone V, Morganti R, D’Amato C, Greco C, Cacciotti L, Marfia GA (2012) Validation of DN4 as a screening tool for neuropathic pain in painful diabetic polyneuropathy. Diabet Med 29(5):578–585. https://doi.org/10.1111/j.1464-5491.2011.03500.x
Padua L, Briani C, Jann S, Nobile-Orazio E, Pazzaglia C, Morini A, Mondelli M, Ciaramitaro P, Cavaletti G, Cocito D, Fazio R, Santoro L, Galeotti F, Carpo M, Plasmati R, Benedetti L, Schenone A, Marchettini P, Cruccu G (2009) Validation of the Italian version of the Neuropathic Pain Symptom Inventory in peripheral nervous system diseases. Neurol Sci 30(2):99–106. https://doi.org/10.1007/s10072-009-0025-y
Beck AT, Ward CH, Mendelson M et al (1961) An inventory for measuring depression. Arch Gen Psychiatry 4(6):561–571. https://doi.org/10.1001/archpsyc.1961.01710120031004
Moulin DE, Foley KM, Ebers GC (1988) Pain syndromes in multiple sclerosis. Neurology 38(12):1830–1834. https://doi.org/10.1212/WNL.38.12.1830
Archibald CJ, McGrath PJ, Ritvo PG, Fisk JD, Bhan V, Maxner CE, Murray TJ (1994) Pain prevalence, severity and impact in a clinic sample of multiple sclerosis patients. Pain 58(1):89–93. https://doi.org/10.1016/0304-3959(94)90188-0
Beiske AG, Pedersen ED, Czujko B, Myhr K-MM (2004) Pain and sensory complaints in multiple sclerosis. Eur J Neurol 11(7):479–482. https://doi.org/10.1111/j.1468-1331.2004.00815.x
Grasso MG, Clemenzi A, Tonini A, Pace L, Casillo P, Cuccaro A, Pompa A, Troisi E (2008) Pain in multiple sclerosis: a clinical and instrumental approach. Mult Scler 14(4):506–513. https://doi.org/10.1177/1352458507085553
Rae-Grant ADD, Eckert NJJ, Bartz S, Reed JF (1999) Sensory symptoms of multiple sclerosis: a hidden reservoir of morbidity. Mult Scler 5(3):179–183. https://doi.org/10.1191/135245899678846032
Warnell P (1991) The pain experience of a multiple sclerosis population: a descriptive study. Axone 13(1):26–28
Unruh AM Gender variations in clinical pain experience. Pain 65:123–167
Truini A, Galeotti F, La Cesa S, di Rezze S, Biasiotta A, di Stefano G, Tinelli E, Millefiorini E, Gatti A, Cruccu G (2012) Mechanisms of pain in multiple sclerosis: a combined clinical and neurophysiological study. Pain 153(10):2048–2054. https://doi.org/10.1016/j.pain.2012.05.024
Holmes A, Christelis N, Arnold C (2013) Depression and chronic pain. Med J Aust 199(6 Suppl):S17–S20
Dworkin RH, Jensen MP, Gammaitoni AR, Olaleye DO, Galer BS (2007) Symptom profiles differ in patients with neuropathic versus non-neuropathic pain. J Pain 8(2):118–126. https://doi.org/10.1016/j.jpain.2006.06.005
Solaro C, Messmer Uccelli M (2011) Management of pain in multiple sclerosis: a pharmacological approach. Nat Rev Neurol 7(9):519–527. https://doi.org/10.1038/nrneurol.2011.120
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
All study procedures were conducted according to the Declaration of Helsinki and were approved by the Modena ethics committee (protocol nr. 181/15). All enrolled subjects presented consent capacity and gave written informed consent to the study.
Conflict of interest
DP received the “Premio Anna Paola Batocchi” 2nd edition from Fondazione Cesare Serono. DF declares that there is no conflict of interest. FM declares that there is no conflict of interest. GD declares that there is no conflict of interest. AMS declares that there is no conflict of interest. FV declares that there is no conflict of interest. PS declares that there is no conflict of interest. GP declares that there is no conflict of interest. VN declares that there is no conflict of interest. MP declares that there is no conflict of interest. MM declares that there is no conflict of interest. CV declares that there is no conflict of interest.
Rights and permissions
About this article
Cite this article
Ferraro, D., Plantone, D., Morselli, F. et al. Systematic assessment and characterization of chronic pain in multiple sclerosis patients. Neurol Sci 39, 445–453 (2018). https://doi.org/10.1007/s10072-017-3217-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10072-017-3217-x